Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 26, 2015	Dec. 27, 2014
Cash flows from operating activities
Net income	$ 661,369	$ 698,381
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	132,731	100,554
Equity compensation expense	38,705	33,445
Deferred income taxes	(971)	(8,636)
Amortization of deferred rent	1,984	3,933
Loss on disposal of fixed assets	2,277	1,802
Amortization of deferred financing costs	637	560
Tax benefits on exercise of share options	(10,815)	(40,220)
Foreign currency losses	3,684	165
Loss on joint venture	982	242
Change in assets and liabilities:
Receivables, net	55,140	(22,548)
Inventories	(65,611)	(125,251)
Prepaid expenses and other current assets	34,248	(42,340)
Other assets	(428)	(8,993)
Accounts payable	47,193	34,881
Accrued expenses and other current liabilities	50,026	63,728
Other long-term liabilities	9,574	19,297
Net cash provided by operating activities	960,725	709,000
Cash flows from investing activities
Capital expenditures	(290,206)	(282,733)
Purchase of intangible assets	(9,414)	(26,150)
Cash received, net of cash consideration paid to obtain controlling interest in MK Panama	4,104	0
Investments in joint venture	(982)	(2,940)
Net cash used in investing activities	(296,498)	(311,823)
Cash flows from financing activities
Repayments of debt obligations	(198,012)	0
Borrowings under credit facility	192,450	0
Repurchase of treasury shares	(952,390)	(403,255)
Tax benefits on exercise of share options	10,815	40,220
Exercise of employee share options	6,506	10,060
Other financing activities	(28)	0
Net cash used in financing activities	(940,659)	(352,975)
Effect of exchange rate changes on cash and cash equivalents	(5,667)	(12,566)
Net (decrease) increase in cash and cash equivalents	(282,099)	31,636
Beginning of period	978,922	971,194
End of period	696,823	1,002,830
Supplemental disclosures of cash flow information
Cash paid for interest	427	537
Cash paid for income taxes	205,846	315,608
Supplemental disclosure of non-cash investing and financing activities
Accrued capital expenditures	$ 45,614	$ 25,790